These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38171242)

  • 1. Natural products in anti-tuberculosis host-directed therapy.
    Huang X; Lowrie DB; Fan XY; Hu Z
    Biomed Pharmacother; 2024 Feb; 171():116087. PubMed ID: 38171242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.
    Zhao L; Fan K; Sun X; Li W; Qin F; Shi L; Gao F; Zheng C
    Front Immunol; 2023; 14():1305325. PubMed ID: 38259491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis.
    Ayodele S; Kumar P; van Eyk A; Choonara YE
    Biomed Pharmacother; 2023 Jun; 162():114588. PubMed ID: 36989709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Directed Therapies for Tuberculosis.
    Jeong EK; Lee HJ; Jung YJ
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
    Tiwari D; Martineau AR
    Semin Immunol; 2023 Jan; 65():101672. PubMed ID: 36469987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-directed therapy against tuberculosis: Concept and recent developments.
    Udinia S; Suar M; Kumar D
    J Biosci; 2023; 48():. PubMed ID: 38088376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.
    Zumla A; Rao M; Dodoo E; Maeurer M
    BMC Med; 2016 Jun; 14():89. PubMed ID: 27301245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis endotypes to guide stratified host-directed therapy.
    DiNardo AR; Nishiguchi T; Grimm SL; Schlesinger LS; Graviss EA; Cirillo JD; Coarfa C; Mandalakas AM; Heyckendorf J; Kaufmann SHE; Lange C; Netea MG; Van Crevel R
    Med; 2021 Mar; 2(3):217-232. PubMed ID: 34693385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-Directed Therapeutic Strategies for Tuberculosis.
    Kolloli A; Subbian S
    Front Med (Lausanne); 2017; 4():171. PubMed ID: 29094039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies.
    Putera I; Schrijver B; Ten Berge JCEM; Gupta V; La Distia Nora R; Agrawal R; van Hagen PM; Rombach SM; Dik WA
    Prog Retin Eye Res; 2023 Jul; 95():101189. PubMed ID: 37236420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs.
    Cubillos-Angulo JM; Nogueira BMF; Arriaga MB; Barreto-Duarte B; Araújo-Pereira M; Fernandes CD; Vinhaes CL; Villalva-Serra K; Nunes VM; Miguez-Pinto JP; Amaral EP; Andrade BB
    Front Med (Lausanne); 2022; 9():970408. PubMed ID: 36213651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remembering the Host in Tuberculosis Drug Development.
    Frank DJ; Horne DJ; Dutta NK; Shaku MT; Madensein R; Hawn TR; Steyn AJC; Karakousis PC; Kana BD; Meintjes G; Laughon B; Tanvir Z
    J Infect Dis; 2019 Apr; 219(10):1518-1524. PubMed ID: 30590592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can We Exploit Inflammasomes for Host-Directed Therapy in the Fight against
    Cebani L; Mvubu NE
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.